AIM
CRVS icon

Avity Investment Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Avity Investment Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Buy
37,150
+3,950
+12% +$54.8K 0.04% 83
2026
Q1 		$486K Buy
33,200
+520
+2% +$8.3K 0.04% 85
2025
Q4 		$252K Hold
32,680
– – 0.02% 99
2025
Q3 		$241K Hold
32,680
– – 0.02% 100
2025
Q2 		$131K Hold
32,680
– – 0.01% 108
2025
Q1 		$104K Buy
32,680
+3,000
+10% +$14.1K 0.01% 102
2024
Q4 		$159K Buy
29,680
+2,100
+8% +$15.7K 0.01% 107
2024
Q3 		$146K Buy
27,580
+16,000
+138% +$57.5K 0.01% 110
2024
Q2 		$21.1K Buy
11,580
+100
+0.9% +$186 ﹤0.01% 107
2024
Q1 		$20.4K Hold
11,480
– – ﹤0.01% 111
2023
Q4 		$20.2K Hold
11,480
– – ﹤0.01% 109
2023
Q3 		$16.8K Buy
+11,480
New +$24.3K ﹤0.01% 87

Other funds holding CRVS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
MCM
Mengis Capital Management Portland, Oregon $658M AUM 39.64% 1-Year Est. Return

Avity Investment Management's CRVS Position: Q2 2026 in Review

Avity Investment Management increased its Corvus Pharmaceuticals (CRVS) stake by 12% in Q2 2026, buying an estimated $54.8K and bringing the position to 37,150 shares worth $555K. The position accounts for 0.04% of the portfolio, ranked #83.

Avity Investment Management first reported a position in CRVS in Q3 2023 and has held it in 12 quarters since. 20 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Avity Investment Management held 37,150 shares of Corvus Pharmaceuticals worth $555K as of Q2 2026.
  • Avity Investment Management bought 3,950 Corvus Pharmaceuticals shares in Q2 2026, an estimated $54.8K.
  • Corvus Pharmaceuticals made up 0.04% of Avity Investment Management's portfolio in Q2 2026, its #83 holding.
  • Avity Investment Management first reported a position in Corvus Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 20 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Avity Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.